China Pharma Balance Sheet - Annual (NYSEMKT:CPHI)

Add to My Stocks
$0.23 $0 (0%) CPHI stock closing price Jun 22, 2018 (Closing)

A thorough fundamental analysis involves using data from China Pharma balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate China Pharma stock analysis. Annual results are typically accompanied with the company releasing financial statements. Apart from analyzing China Pharma revenue China Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The China Pharma balance sheet for 2017 shows cash on hand of $2.74M. The company has a debt to equity ratio of 0.23.

View latest 10 year balance sheet data to check China Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities----------
Raw Materials4.73M11.56M14.69M18.81M28.25M30.19M24.92M16.25M9.35M10.83M
Work In Progress----------
Finished Goods1.19M1.53M3.38M3.43M3.59M7.93M5.45M4.13M4.87M2.19M
Notes Receivable----------
Other Current Assets-2.23M2.87M8.29M7.62M6.75M6.91M6.36M2.43M3.95M
Total Current Assets
Property Plant & Equipment39.06M36.46M38.81M40.52M35.5M13.3M9.72M9.06M8.72M8.22M
Accumulated Depreciation15.52M11.5M9.42M6.64M5.26M4.27M3.39M2.69M2.02M1.48M
Net Property Plant & Equipment
Investment & Advances23.72M35.49M42.03M42.39M41.7M39.26M36.19M4.39M3.59M2.83M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable-1.08M4.62M4.88M4.9M4.76M3.93M3.78M3.8M2.48M
Accounts Payable1.14M3.06M2.82M2.55M1.87M2.84M3.11M4.93M3.95M1.04M
Current Portion Long-Term Debt2.3M1.44M1.54M1.62M------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable-----2.42M3.08M2.38M1.52M1.17M
Other Current Liabilities4.79M4.66M3.66M4.83M4.89M4.39M3.46M1.6M1.17M-
Total Current Liabilities
Deferred Taxes/Income--1M-------
Convertible Debt----------
Long-Term Debt6.91M8.64M10.78M11.4M12.48M-----
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus23.59M23.59M23.59M23.59M23.59M23.59M23.44M23.25M21.17M21.06M
Retained Earnings5.47M24.75M33.94M62.84M88.89M108.9M104.28M85.01M63.27M43.03M
Treasury Stock----------
Other Liabilities13.95M10.51M15.06M19.77M20.41M15.97M14.7M9.62M5.9M5.71M
Shareholders Equity43.07M58.9M72.64M106.25M132.94M148.51M142.48M117.93M90.39M69.86M
Total Liabilities & Shareholders Equity59.95M78.52M97.22M132.08M157.61M163.23M156.39M131.75M100.94M75.47M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Mylan financial analysis

Apart from balance sheet items, an investor would do well to keep track of the China Pharma stock price by looking at China Pharma historical stock prices. One can compare PE with industry average by looking at the China Pharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like China Pharma owns and has monetary significance. CPHI assets decreased from $78.52M in 2016 to $59.95M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. CPHI stock had total liabilities of $16.88M for the year 2017.

China Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio